Handelsbanken Fonder
EPZM

Handelsbanken Fonder’s Epizyme, Inc EPZM Stock Holding History

Handelsbanken Fonder’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-23,400
Closed -$120K – 1775
2021
Q3 		$120K Hold
23,400
– – ﹤0.01% 1670
2021
Q2 		$194K Buy
23,400
+5,200
+29% +$43.8K ﹤0.01% 1697
2021
Q1 		$159K Hold
18,200
– – ﹤0.01% 1551
2020
Q4 		$198K Hold
18,200
– – ﹤0.01% 1524
2020
Q3 		$217K Hold
18,200
– – ﹤0.01% 1369
2020
Q2 		$292K Buy
+18,200
New +$318K ﹤0.01% 1234

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Handelsbanken Fonder's EPZM Position: Q4 2021 in Review

Handelsbanken Fonder sold out of Epizyme, Inc (EPZM) in Q4 2021, closing a stake of 23,400 shares — an estimated $120K sold.

Handelsbanken Fonder first reported a position in EPZM in Q2 2020 and held it in 6 quarters. The position peaked at $292K in Q2 2020. 132 funds tracked by Wall St. Rank hold EPZM as of Q4 2021.

  • Handelsbanken Fonder reported no remaining Epizyme, Inc position as of Q4 2021 after selling out during the quarter.
  • Handelsbanken Fonder sold 23,400 Epizyme, Inc shares in Q4 2021, an estimated $120K.
  • Handelsbanken Fonder first reported a position in Epizyme, Inc in Q2 2020 and held it in 6 quarters.
  • Handelsbanken Fonder's Epizyme, Inc position peaked at $292K in Q2 2020.
  • 132 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2021.

Based on Handelsbanken Fonder's 13F filing for Q4 2021, filed 8 Feb 2022.